Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage and Hearing Loss in Infant Rat Pneumococcal Meningitis.

Muri, Lukas; Perny, Michael; Zemp, Jonas; Grandgirard, Denis; Leib, Stephen L. (2019). Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage and Hearing Loss in Infant Rat Pneumococcal Meningitis. Antimicrobial agents and chemotherapy, 63(7) American Society for Microbiology 10.1128/AAC.00220-19

[img]
Preview
Text
Antimicrobial Agents and Chemotherapy-2019-Muri-AAC.00220-19.full.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (5MB) | Preview
[img] Text
Antimicrobial Agents and Chemotherapy-2019-Muri-e00220-19.full.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB) | Request a copy

Despite available antibiotic therapy, pneumococcal meningitis (PM) is associated with a case fatality rate of up to 30% in high-income countries. Survivors often suffer from severe lifelong disabilities. An excessive inflammatory reaction drives the pathophysiology leading to brain damage and neurologic sequelae. We aimed to improve the outcome of experimental PM by simultaneously targeting different pathophysiological mechanisms with combined adjunctive therapies previously shown to be neuroprotective. , the anti-inflammatory effect of doxycycline and daptomycin were evaluated on primary rat astroglial cells stimulated with Eleven day old infant Wistar rats were infected intracisternally with and randomized for treatment with ceftriaxone or combination adjuvant therapy consisting of ceftriaxone, daptomycin and doxycycline. During acute PM, combined adjuvant therapy with ceftriaxone, daptomycin and doxycycline increased survival rate from 64.1% to 85.8% (p<0.01) and alleviated weight loss compared to ceftriaxone monotherapy (p<0.01). Levels of inflammatory cytokines were significantly reduced by combined adjuvant therapy (p<0.0001) and in cerebrospinal fluid (p<0.05). In infected animals treated with combined adjunctive therapy, cortical damage was significantly reduced (p<0.05) and they showed a trend towards better hearing capacity three weeks after the infection (p=0.089), an effect which was significant in mildly infected animals (48dB vs 67.22dB, p<0.05). These mildly infected animals showed significantly reduced cochlear fibrous occlusion (p<0.01). By combining non-bacteriolytic daptomycin and anti-inflammatory doxycycline with ceftriaxone, their previously reported beneficial effects were cumulated and identified the triple antibiotic therapy as a promising therapeutic option for paediatric PM.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases
04 Faculty of Medicine > Service Sector > Institute for Infectious Diseases > Research

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)

UniBE Contributor:

Leib, Stephen

Subjects:

500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health

ISSN:

0066-4804

Publisher:

American Society for Microbiology

Funders:

[4] Swiss National Science Foundation

Language:

English

Submitter:

Stephen Leib

Date Deposited:

31 Jul 2019 10:18

Last Modified:

01 Jan 2020 02:30

Publisher DOI:

10.1128/AAC.00220-19

PubMed ID:

31061158

Uncontrolled Keywords:

Pneumococcal meningitis, brain injury, neurologic sequelae, neuroinflammation, hearing loss, combination adjuvant therapy

BORIS DOI:

10.7892/boris.130593

URI:

https://boris.unibe.ch/id/eprint/130593

Actions (login required)

Edit item Edit item
Provide Feedback